Difference between revisions of "Part:BBa K3994009"
(3 intermediate revisions by the same user not shown) | |||
Line 3: | Line 3: | ||
<partinfo>BBa_K3994009 short</partinfo> | <partinfo>BBa_K3994009 short</partinfo> | ||
− | PttB344_HrpS_PJ23105_ttrR | + | promoter |
+ | |||
+ | === Profile === | ||
+ | |||
+ | |||
+ | ==== Name: PttB344_HrpS_PJ23105_ttrR ==== | ||
+ | ==== Base Pairs: 2040 bp ==== | ||
+ | ==== Origin: Synthetic ==== | ||
+ | ==== Properties: A biosensor releasing fluorescence only when detecting the IBD marker. ==== | ||
+ | |||
+ | |||
+ | === Usage and Biology === | ||
+ | |||
+ | ==== Background ==== | ||
+ | |||
+ | |||
+ | Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory disease of unknown etiology, including ulcerative colitis (CD) and Crohn’s disease (CD). This chronic disease, which is prone to repeated deterioration, currently lacks unified diagnostic and treatment standards, and is posing a great threat to public health. Drug therapy (anti-inflammatory drugs) is the preferred treatment for IBD. However, studies in the past 10 years have found that 30-50% of IBD patients do not respond to anti-TNF treatment. In addition, after long-term use of anti-inflammatory drugs, the patient's intestinal microbial status changes over time, and the effect may be lost due to drug resistance. Therefore, we need to seek help from other treatments for IBD. HrpR protein binds to HrpS protein forming a complex and then triggering the transcription of promoter hrpL. It can sense S4O62- to release the substance S | ||
+ | |||
+ | |||
+ | === Construct design === | ||
+ | |||
+ | HrpS is a key functional factor under PttB344 promoter (Figure 1). And this sequence is inserted into plasmid. Its sequence is shown in Figure 2. | ||
+ | |||
+ | [[File:T--NOFLS YZ--BBa K3994009-Figure1.png|500px|thumb|center|Figure 1. Boolean gate logic circuit/AND circuit construction...]] | ||
+ | |||
+ | |||
+ | [[File:T--NOFLS YZ--BBa K3994009-Figure2.png|500px|thumb|center|Figure 2. PttB344_HrpS_PJ23105_ttrR, sensing S4O62- to release the substance S...]] | ||
+ | |||
+ | |||
+ | The profiles of every basic part are as follows: | ||
+ | |||
+ | === BBa_K3994003 === | ||
+ | ==== Name: HrpS ==== | ||
+ | ==== Base Pairs: 912bp ==== | ||
+ | ==== Origin: Pseudomonas syringae, genome ==== | ||
+ | ==== Properties: A coding sequence of HrpS protein ==== | ||
+ | |||
+ | === Usage and Biology === | ||
+ | |||
+ | This codes for HrpS protein. HrpR protein binds to HrpS protein forming a complex and then triggering the transcription of promoter hrpL. This functions like a AND logic gate. | ||
+ | |||
+ | === BBa_K3994012 === | ||
+ | |||
+ | ==== Name: PttB344 ==== | ||
+ | ==== Base Pairs: 85bp ==== | ||
+ | ==== Origin: Synthetic ==== | ||
+ | ==== Properties: A coding sequence of promoter ttB344. ==== | ||
+ | |||
+ | === Usage and Biology === | ||
+ | |||
+ | This is a sequence of PttB344. PttrB185-269 is a minimal TtrR activated promoter when TtrR is phosphorylated by TtrS after TtrS sensing tetrathionate. | ||
+ | |||
+ | === Experimental approach === | ||
+ | |||
+ | ==== Recombinant Plasmid Construction ==== | ||
+ | |||
+ | [[File:T--NOFLS YZ--BBa K3994001-Figure1.png|500px|thumb|center|Figure 3. The electrophoresis results of enzyme digestion and PCR...]] | ||
+ | |||
+ | |||
+ | Lane 1 and 2: Plasmid pSU2718-p15A digested by Xba1 and BamH1. | ||
+ | |||
+ | Lane 3: Part 2, PttB344_HrpS_PJ23105_ttrR, got by PCR method with size of 2060bp. | ||
+ | |||
+ | |||
+ | This step is used to get the plasmids pSU2718-p15A digested by enzyme Xba1 and BamH1and gene PttB344_HrpS_PJ23105_ttrR by PCR method for later in the process. Therefore, channel 1 and 2 were plasmids pSU2718-p15A digested by enzyme Xba1 and BamH1. And channel 3 were gene PttB344_HrpS_PJ23105_ttrR got by PCR. Clean-up the product to obtain pSU2718-p15A backbone and PttB344_HrpS_PJ23105_ttrR-fragment. | ||
+ | T4 DNA ligase is used to connect pSU2718-p15A backbone and PttB344_HrpS_PJ23105_ttrR-fragment to get plasmid pSU2718-part2. | ||
+ | |||
+ | |||
+ | [[File:T--NOFLS YZ--BBa K3994001-Figure2.png|500px|thumb|center|Figure 4 E-coil having the desired pSU2718-part2 (Left) and control (Right)...]] | ||
+ | |||
+ | |||
+ | [[File:T--NOFLS YZ--BBa K3994001-Figure5.0.png|500px|thumb|center|Figure 5. The electrophoresis result of enzyme digestion identification...]] | ||
+ | |||
+ | |||
+ | [[File:T--NOFLS YZ--BBa K3994001-Figure3.png|500px|thumb|center|Figure 5. The electrophoresis result of enzyme digestion identification...]] | ||
+ | |||
+ | Lane 1: Plasmid pSU2718-p15A digested by EcoR1. | ||
+ | |||
+ | Lane 2 to 5: Recombinant plasmid pSU2718-part2 digested by EcoRI. We got two bands with size of 2803bp and 1544bp. | ||
+ | |||
+ | The results show that we got the correct plasmid. And the plasmid was sent to sequence. | ||
+ | |||
+ | |||
+ | [[File:T--NOFLS YZ--BBa K3994001-Figure4.png|500px|thumb|center|Figure 6 The result of sequencing for plasmid pSU2718-part2...]] | ||
+ | |||
+ | Sequencing feedback shows we have obtained the correct plasmids which is consistent with their DNA profiles. | ||
+ | |||
+ | === Proof of function === | ||
+ | |||
+ | ==== Attempt 1 ==== | ||
+ | [[File:T--NOFLS YZ--BBa K3994003-Figure5.jpg|500px|thumb|center|Figure 7. Genetic Construction of IBD Distinguisher...]] | ||
+ | |||
+ | |||
+ | Sample 1: Negative Control (E. coli) | ||
+ | |||
+ | Sample 2: Positive Control (E. coli/amilGFP) | ||
+ | |||
+ | Sample 3: E. coli/pUC-57_Part 3 | ||
+ | |||
+ | Sample 4: E.coli/pSU2718-Part 1_Part 2+pUC-57_Part 3 | ||
+ | |||
+ | |||
+ | In order to further analyze the performance of Part 2, we also designed the control groups as showing above where Sample 1 and Sample 2 were presented as the comparison of the fluorescence phenomenon. We can see that there was no fluorescence in Sample 3 (the report part, Part 3). According to the result of Sample 3 and Sample 4 (Figure 7), we could infer that the AND gate design works (HrpR_HrpS, PhrpL) as the Part 3 didn’t respond when there is no Part 1 and Part 2. | ||
+ | Of course, we also repeated the experiments and measured the fluorescence intensity by ELIASA. The data is given below. | ||
+ | |||
+ | [[File:T--NOFLS YZ--BBa K3994003-table2.png|500px|thumb|center|Table 2...]] | ||
+ | |||
+ | [[File:T--NOFLS YZ--BBa K3994003-Figure6.png|500px|thumb|center|Figure 8. Histograms of the fluorescence intensity of samples in Table 2...]] | ||
+ | |||
+ | [[File:T--NOFLS YZ--BBa K3994003-Figure7.png|500px|thumb|center|Figure 9. Trend Contrast of the fluorescence intensity between that under OD600=0.8 and that under OD600=1...]] | ||
+ | |||
+ | |||
+ | According to the trend in Figure 9, the fluorescence intensity of pUC57-Part 3 presents the similar level as that of blank control and group NO3-, which means the “gate keeper” promoter, PhrpL works well and this conclusion also back up the conclusion that the AND gate design works well (HrpR_HrpS, PhrpL). | ||
+ | |||
+ | As the group S4O62 did present higher fluorescence intensity than that of group NO3- whenever OD600 equals to 0.8 or 1, it indicates that Part 2 and Part 3 both works well as Part 2 did show “green light” to the thiosulfate to finally “light” the Part 3. | ||
+ | |||
+ | === References === | ||
+ | |||
+ | ==== 1 CDC -What is inflammatory bowel disease, available at: https://www.cdc.gov/ibd/what-is-ibd.htm ==== | ||
+ | ==== 2炎症性肠病 百度百科available at: https://baike.baidu.com/item/%E7%82%8E%E6%80%A7%E8%82%A0%E7%97%85/5296499?fr=aladdin ==== | ||
+ | ==== 3 Data and StatisticsInflammatory Bowel Disease (IBD) in the United StatesAvailable at: https://www.cdc.gov/ibd/data-statistics.htm ==== | ||
+ | ==== 4. Wang, Baojun, et al. "Engineering modular and orthogonal genetic logic gates for robust digital-like synthetic biology." Nature communications 2.1 (2011): 1-9. ==== | ||
+ | |||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here |
Latest revision as of 10:37, 19 October 2021
PttB344_HrpS_PJ23105_ttrR
promoter
Profile
Name: PttB344_HrpS_PJ23105_ttrR
Base Pairs: 2040 bp
Origin: Synthetic
Properties: A biosensor releasing fluorescence only when detecting the IBD marker.
Usage and Biology
Background
Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory disease of unknown etiology, including ulcerative colitis (CD) and Crohn’s disease (CD). This chronic disease, which is prone to repeated deterioration, currently lacks unified diagnostic and treatment standards, and is posing a great threat to public health. Drug therapy (anti-inflammatory drugs) is the preferred treatment for IBD. However, studies in the past 10 years have found that 30-50% of IBD patients do not respond to anti-TNF treatment. In addition, after long-term use of anti-inflammatory drugs, the patient's intestinal microbial status changes over time, and the effect may be lost due to drug resistance. Therefore, we need to seek help from other treatments for IBD. HrpR protein binds to HrpS protein forming a complex and then triggering the transcription of promoter hrpL. It can sense S4O62- to release the substance S
Construct design
HrpS is a key functional factor under PttB344 promoter (Figure 1). And this sequence is inserted into plasmid. Its sequence is shown in Figure 2.
The profiles of every basic part are as follows:
BBa_K3994003
Name: HrpS
Base Pairs: 912bp
Origin: Pseudomonas syringae, genome
Properties: A coding sequence of HrpS protein
Usage and Biology
This codes for HrpS protein. HrpR protein binds to HrpS protein forming a complex and then triggering the transcription of promoter hrpL. This functions like a AND logic gate.
BBa_K3994012
Name: PttB344
Base Pairs: 85bp
Origin: Synthetic
Properties: A coding sequence of promoter ttB344.
Usage and Biology
This is a sequence of PttB344. PttrB185-269 is a minimal TtrR activated promoter when TtrR is phosphorylated by TtrS after TtrS sensing tetrathionate.
Experimental approach
Recombinant Plasmid Construction
Lane 1 and 2: Plasmid pSU2718-p15A digested by Xba1 and BamH1.
Lane 3: Part 2, PttB344_HrpS_PJ23105_ttrR, got by PCR method with size of 2060bp.
This step is used to get the plasmids pSU2718-p15A digested by enzyme Xba1 and BamH1and gene PttB344_HrpS_PJ23105_ttrR by PCR method for later in the process. Therefore, channel 1 and 2 were plasmids pSU2718-p15A digested by enzyme Xba1 and BamH1. And channel 3 were gene PttB344_HrpS_PJ23105_ttrR got by PCR. Clean-up the product to obtain pSU2718-p15A backbone and PttB344_HrpS_PJ23105_ttrR-fragment.
T4 DNA ligase is used to connect pSU2718-p15A backbone and PttB344_HrpS_PJ23105_ttrR-fragment to get plasmid pSU2718-part2.
Lane 1: Plasmid pSU2718-p15A digested by EcoR1.
Lane 2 to 5: Recombinant plasmid pSU2718-part2 digested by EcoRI. We got two bands with size of 2803bp and 1544bp.
The results show that we got the correct plasmid. And the plasmid was sent to sequence.
Sequencing feedback shows we have obtained the correct plasmids which is consistent with their DNA profiles.
Proof of function
Attempt 1
Sample 1: Negative Control (E. coli)
Sample 2: Positive Control (E. coli/amilGFP)
Sample 3: E. coli/pUC-57_Part 3
Sample 4: E.coli/pSU2718-Part 1_Part 2+pUC-57_Part 3
In order to further analyze the performance of Part 2, we also designed the control groups as showing above where Sample 1 and Sample 2 were presented as the comparison of the fluorescence phenomenon. We can see that there was no fluorescence in Sample 3 (the report part, Part 3). According to the result of Sample 3 and Sample 4 (Figure 7), we could infer that the AND gate design works (HrpR_HrpS, PhrpL) as the Part 3 didn’t respond when there is no Part 1 and Part 2.
Of course, we also repeated the experiments and measured the fluorescence intensity by ELIASA. The data is given below.
According to the trend in Figure 9, the fluorescence intensity of pUC57-Part 3 presents the similar level as that of blank control and group NO3-, which means the “gate keeper” promoter, PhrpL works well and this conclusion also back up the conclusion that the AND gate design works well (HrpR_HrpS, PhrpL).
As the group S4O62 did present higher fluorescence intensity than that of group NO3- whenever OD600 equals to 0.8 or 1, it indicates that Part 2 and Part 3 both works well as Part 2 did show “green light” to the thiosulfate to finally “light” the Part 3.
References
1 CDC -What is inflammatory bowel disease, available at: https://www.cdc.gov/ibd/what-is-ibd.htm
2炎症性肠病 百度百科available at: https://baike.baidu.com/item/%E7%82%8E%E6%80%A7%E8%82%A0%E7%97%85/5296499?fr=aladdin
3 Data and StatisticsInflammatory Bowel Disease (IBD) in the United StatesAvailable at: https://www.cdc.gov/ibd/data-statistics.htm
4. Wang, Baojun, et al. "Engineering modular and orthogonal genetic logic gates for robust digital-like synthetic biology." Nature communications 2.1 (2011): 1-9.
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal XbaI site found at 25
Illegal XbaI site found at 175
Illegal PstI site found at 13 - 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 839
Illegal NheI site found at 862
Illegal PstI site found at 13 - 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 1893
Illegal BamHI site found at 31 - 23INCOMPATIBLE WITH RFC[23]Illegal XbaI site found at 25
Illegal XbaI site found at 175
Illegal PstI site found at 13 - 25INCOMPATIBLE WITH RFC[25]Illegal XbaI site found at 25
Illegal XbaI site found at 175
Illegal PstI site found at 13
Illegal AgeI site found at 553
Illegal AgeI site found at 1106
Illegal AgeI site found at 1112
Illegal AgeI site found at 1247 - 1000COMPATIBLE WITH RFC[1000]